A Randomized Phase II Trial of Three Intensified Chemotherapy Regimens in First-Line Treatment of Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases. The METHEP Trial

Author： Ychou Marc   Rivoire Michel   Thezenas Simon   Quenet François   Delpero Jean-Robert   Rebischung Christine   Letoublon Christian   Guimbaud Rosine   Francois Eric   Ducreux Michel   Desseigne Françoise   Fabre Jean-Michel   Assenat Eric  

Publisher： Springer Publishing Company

ISSN： 1068-9265

Source： Annals of Surgical Oncology, Vol.20, Iss.13, 2013-12, pp. : 4289-4297

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: A Korean Cancer Study Group Trial

By Kim Tae Won   Kang Won Ki   Chang Heung Moon   Park Joon Oh   Ryoo Baek Yeol   Ahn Jin Seok   Zang Dae Young   Lee Kyung Hee   Kang Yoon Koo   Kim Sung Rok   Kim Hoon-Kyo  

Acta Oncologica, Vol. 44, Iss. 3, 2005-05 ,pp. : 230-235

Informa Healthcare

Access to resources Recommend Favorite

A Phase II Trial of Oxaliplatin, Folinic Acid, and 5-Fluorouracil (FOLFOX4) as First-Line Chemotherapy in Advanced Colorectal Cancer: A China Single-Center Experience

By Xu Nong   Fang Wei-Jia   Zhang Xiao-Chen   Yu Lan-Fang   Bao Han-Ying   Shi Gen-Ming   Huang Sui   Shen Peng  

Cancer Investigation, Vol. 25, Iss. 7, 2007-09 ,pp. : 599-605

Informa Healthcare

Access to resources Recommend Favorite

A Phase I Trial of Isolated Hepatic Perfusion (IHP) Using 5-FU and Oxaliplatin in Patients with Unresectable Isolated Liver Metastases from Colorectal Cancer

By Magge D.   Zureikat A.   Bartlett D.   Holtzman M.   Choudry H.   Beumer J.   Pingpank J.   Holleran J.   Strychor S.   Cunningham D.   Jones H.   Zeh H.  

Annals of Surgical Oncology, Vol. 20, Iss. 7, 2013-07 ,pp. : 2180-2187

Springer Publishing Company

Access to resources Recommend Favorite

Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study

By Takahashi Takao  

International Journal of Clinical Oncology, Vol. 18, Iss. 2, 2013-04 ,pp. : 335-342

Springer Publishing Company

Access to resources Recommend Favorite

Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial

By Hatschek T.   Carlsson L.   Einbeigi Z.   Lidbrink E.   Linderholm B.   Lindh B.   Loman N.   Malmberg M.   Rotstein S.   Söderberg M.   Sundquist M.   Walz T.   Hellström M.   Svensson H.   Åström G.   Brandberg Y.   Carstensen J.   Fernö M.   Bergh J.  

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 939-947

Springer Publishing Company

Access to resources Recommend Favorite